APA (7th ed.) Citation

DJ, B., J, E., K, B., P, S., K, L., SB, C., . . . JA, P. (2017). Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: A randomized, double-blind, placebo-controlled study. Lupus, 26(8), 825. https://doi.org/10.1177/0961203316678675

Chicago Style (17th ed.) Citation

DJ, Burge, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of RSLV-132, an RNase-Fc Fusion Protein in Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled Study." Lupus 26, no. 8 (2017): 825. https://doi.org/10.1177/0961203316678675.

MLA (9th ed.) Citation

DJ, Burge, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of RSLV-132, an RNase-Fc Fusion Protein in Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled Study." Lupus, vol. 26, no. 8, 2017, p. 825, https://doi.org/10.1177/0961203316678675.